GSK573719/Vilanterol (125/25 mcg)

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK573719/Vilanterol (125/25 mcg), covering 2014-02-10 to 2014-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD [Phase 3]